Clinical Trials in Canada / NCT02760238
Recruiting
Observational
Myeloproliferative Neoplasms (MPNs) Patient Registry
NCT02760238 · tracked via the Priya Life Science Canada tracker
Condition(s) studied
Primary MyelofibrosisPolycythemia VeraEssential ThrombocythemiaMastocytosisLeukemia, Myeloid, Chronic, Atypical, BCR-ABL NegativeLeukemia, Myelomonocytic, JuvenileChronic Eosinophilic Leukemia-not Otherwise SpecifiedMyelodysplastic-Myeloproliferative DiseasesNeoplasmsLeukemia, Myelomonocytic, Chronic
Investigational drug(s) / intervention(s)
Observational
Study summary
The mandate of this MPN registry is to collect clinical information, including molecular results, from consenting patients with a variety of MPNs at different time points during the course of their disease.
Eligibility
Inclusion Criteria:
Diagnosis of one of the following myeloproliferative neoplasms (MPNs):
* Atypical CML (aCML)
* Chronic eosinophilic leukemia-not otherwise specified (CEL, NOS),
* Chronic myelomonocytic leukemia (CMML)
* Chronic neutrophilic leukemia (CNL),
* Essential thrombocythemia (ET),
* Juvenile myelomonocytic leukemia (JMML),
* Mastocytosis, MPN unclassifiable
* MPN/MDS unclassifiable,
* Primary myelofibrosis (PMF),
* Post-essential thrombocythemia myelofibrosis (post-ET MF),
* Post-polycythemia vera MF (post-PV MF)
* Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T)
Exclusion Criteria:
* None
Primary outcome measure(s)
- Survival — Annually or at the time of transformation of disease, up to 10 years
Survival of patients with MPN
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Princess Margaret Cancer Centre | Toronto | Ontario | Recruiting |
More University Health Network, Toronto trials in Canada
Effects of Teriparatide (PTH) on Bone in Men and Women With Osteoporosis
Active, not recruiting
Province of Ontario Strategy for Personalized Management of Pancreatic Cancer Trial
Active, not recruiting
Other trials for the same condition
Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)
Active, not recruiting
A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV
Active, not recruiting
Alberta Cancer Exercise Hybrid Effectiveness-Implementation Study
Active, not recruiting
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT02760238 on ClinicalTrials.gov ↗ ← All trials in Canada